ENVUE MEDICAL INC.
COM NEW · CUSIP 63008J884
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.51.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2025 | 6 |
| Q4 2025 | 6 |
| Q1 2026 | 13 |
| Q2 2026 | 13 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2025 | 4 | 1 |
| Q1 2026 | 9 | 4 |
| Q2 2026 | 6 | 7 |
Biggest buyers
| HRT FINANCIAL LP | New | +115.6k |
| Virtu Financial LLC | New | +95.3k |
| JANE STREET GROUP, LLC | New | +37.6k |
| TWO SIGMA SECURITIES, LLC | New | +10.3k |
| Tower Research Capital LLC (TRC) | Added | +2.0k |
| Caitong International Asset Management Co., Ltd | New | +1 |
Biggest sellers
| Schonfeld Strategic Advisors LLC | Sold out | -13.5k |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | Sold out | -10.0k |
| MORGAN STANLEY | Sold out | -10.0k |
| Poehling Capital Management, INC. | Sold out | -10.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -7.0k |
| FMR LLC | Sold out | -324 |
| UBS Group AG | Sold out | -24 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Glibert Christian Michael
13D · may seek influence
filed 2026-04-17
Stated purposeThis Amendment No. 1 to Schedule 13D is being filed to report a material change in the Reporting Person's percentage of beneficial ownership of the Issuer's Common Stock. Since the filing of the initial Schedule 13D on February 11, 2026, the Issuer's total shares outstanding increased from 1,088,192 to 3,700,908, as reported in the Issuer's Annual Report on Form 10-K filed on April 15, 2026. This increase in outstanding shares resulted in the dilution of the Reporting Person's beneficial ownership from approximately 22.1 percent to approximately 6.5 percent. The Reporting Person has not acquired or disposed of any shares of Common Stock since the initial filing. The Reporting Person continues to hold the shares for investment purposes and may, from time to time, purchase additional shares… Full filing |
6.5% |
Fell to 5% or below in the last year: BANK OF AMERICA CORP /DE/ (0.0%, 2026-03-06)
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| HRT FINANCIAL LP 0.00% of their portfolio | 115.6k $59.0k | New |
| Virtu Financial LLC 0.00% of their portfolio | 95.3k $49.0k | New |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 37.6k $19.4k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 15.5k $8.0k | Reduced -7.0k |
| TWO SIGMA SECURITIES, LLC 0.00% of their portfolio | 10.3k $5.3k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 10.0k $5.2k | Unchanged |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 4.8k $2.5k | Added +2.0k |
| Global Retirement Partners, LLC 0.00% of their portfolio | 1.6k $824 | First filing |
| VANGUARD CAPITAL MANAGEMENT LLC 0.00% of their portfolio | 189 $97 | Unchanged |
| VANGUARD FIDUCIARY TRUST CO 0.00% of their portfolio | 85 $44 | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 45 $23 | Unchanged |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 15 $8 | Unchanged |
| Caitong International Asset Management Co., Ltd 0.00% of their portfolio | 1 $1 | New |